These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 27079728)

  • 21. Glucocorticoids facilitate astrocytic amyloid-β peptide deposition by increasing the expression of APP and BACE1 and decreasing the expression of amyloid-β-degrading proteases.
    Wang Y; Li M; Tang J; Song M; Xu X; Xiong J; Li J; Bai Y
    Endocrinology; 2011 Jul; 152(7):2704-15. PubMed ID: 21558319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The amyloid-β₄₂ proxy, amyloid-β(25-35), induces normal human cerebral astrocytes to produce amyloid-β₄₂.
    Dal Prà I; Whitfileld JF; Pacchiana R; Bonafini C; Talacchi A; Chakravarthy B; Armato U; Chiarini A
    J Alzheimers Dis; 2011; 24(2):335-47. PubMed ID: 21258151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual pathways mediate β-amyloid stimulated glutathione release from astrocytes.
    Ye B; Shen H; Zhang J; Zhu YG; Ransom BR; Chen XC; Ye ZC
    Glia; 2015 Dec; 63(12):2208-19. PubMed ID: 26200696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice.
    Yamamoto M; Kiyota T; Horiba M; Buescher JL; Walsh SM; Gendelman HE; Ikezu T
    Am J Pathol; 2007 Feb; 170(2):680-92. PubMed ID: 17255335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tomoregulin (TMEFF2) Binds Alzheimer's Disease Amyloid-β (Aβ) Oligomer and AβPP and Protects Neurons from Aβ-Induced Toxicity.
    Hong HS; Maezawa I; Petrlova J; Zhao XY; C Voss J; Jin LW
    J Alzheimers Dis; 2015; 48(3):731-43. PubMed ID: 26402097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oligodendrocytes damage in Alzheimer's disease: beta amyloid toxicity and inflammation.
    Roth AD; Ramírez G; Alarcón R; Von Bernhardi R
    Biol Res; 2005; 38(4):381-7. PubMed ID: 16579521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer's disease.
    Hartlage-Rübsamen M; Waniek A; Meissner J; Morawski M; Schilling S; Jäger C; Kleinschmidt M; Cynis H; Kehlen A; Arendt T; Demuth HU; Rossner S
    Acta Neuropathol; 2015 Apr; 129(4):565-83. PubMed ID: 25666182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. β-amyloid and ATP-induced diffusional trapping of astrocyte and neuronal metabotropic glutamate type-5 receptors.
    Shrivastava AN; Kowalewski JM; Renner M; Bousset L; Koulakoff A; Melki R; Giaume C; Triller A
    Glia; 2013 Oct; 61(10):1673-86. PubMed ID: 23922225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Galantamine attenuates amyloid-β deposition and astrocyte activation in APP/PS1 transgenic mice.
    Wu Z; Zhao L; Chen X; Cheng X; Zhang Y
    Exp Gerontol; 2015 Dec; 72():244-50. PubMed ID: 26521029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcineurin in reactive astrocytes plays a key role in the interplay between proinflammatory and anti-inflammatory signals.
    Fernandez AM; Fernandez S; Carrero P; Garcia-Garcia M; Torres-Aleman I
    J Neurosci; 2007 Aug; 27(33):8745-56. PubMed ID: 17699657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of a tacrine-8-hydroxyquinoline hybrid (IQM-622) on Aβ accumulation and cell death: involvement in hippocampal neuronal loss in Alzheimer's disease.
    Antequera D; Bolos M; Spuch C; Pascual C; Ferrer I; Fernandez-Bachiller MI; Rodríguez-Franco MI; Carro E
    Neurobiol Dis; 2012 Jun; 46(3):682-91. PubMed ID: 22426395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Caffeine, Through Adenosine A3 Receptor-Mediated Actions, Suppresses Amyloid-β Protein Precursor Internalization and Amyloid-β Generation.
    Li S; Geiger NH; Soliman ML; Hui L; Geiger JD; Chen X
    J Alzheimers Dis; 2015; 47(1):73-83. PubMed ID: 26402756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perturbed Calcineurin-NFAT Signaling Is Associated with the Development of Alzheimer's Disease.
    Asai M; Kinjo A; Kimura S; Mori R; Kawakubo T; Shirotani K; Yagishita S; Maruyama K; Iwata N
    Biol Pharm Bull; 2016; 39(10):1646-1652. PubMed ID: 27725441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro and in vivo activation of astrocytes by amyloid-beta is potentiated by pro-oxidant agents.
    García-Matas S; de Vera N; Aznar AO; Marimon JM; Adell A; Planas AM; Cristòfol R; Sanfeliu C
    J Alzheimers Dis; 2010; 20(1):229-45. PubMed ID: 20164580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calpain-Mediated Alterations in Astrocytes Before and During Amyloid Chaos in Alzheimer's Disease.
    Schultz B; Taday J; Menezes L; Cigerce A; Leite MC; Gonçalves CA
    J Alzheimers Dis; 2021; 84(4):1415-1430. PubMed ID: 34719501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The calcineurin inhibitor Sarah (Nebula) exacerbates Aβ42 phenotypes in a Drosophila model of Alzheimer's disease.
    Lee S; Bang SM; Hong YK; Lee JH; Jeong H; Park SH; Liu QF; Lee IS; Cho KS
    Dis Model Mech; 2016 Mar; 9(3):295-306. PubMed ID: 26659252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of phagocytic activity in astrocytes by reduced expression of the inflammasome component ASC and its implication in a mouse model of Alzheimer disease.
    Couturier J; Stancu IC; Schakman O; Pierrot N; Huaux F; Kienlen-Campard P; Dewachter I; Octave JN
    J Neuroinflammation; 2016 Jan; 13():20. PubMed ID: 26818951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simvastatin and atorvastatin facilitates amyloid β-protein degradation in extracellular spaces by increasing neprilysin secretion from astrocytes through activation of MAPK/Erk1/2 pathways.
    Yamamoto N; Fujii Y; Kasahara R; Tanida M; Ohora K; Ono Y; Suzuki K; Sobue K
    Glia; 2016 Jun; 64(6):952-62. PubMed ID: 26875818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ibuprofen suppresses interleukin-1beta induction of pro-amyloidogenic alpha1-antichymotrypsin to ameliorate beta-amyloid (Abeta) pathology in Alzheimer's models.
    Morihara T; Teter B; Yang F; Lim GP; Boudinot S; Boudinot FD; Frautschy SA; Cole GM
    Neuropsychopharmacology; 2005 Jun; 30(6):1111-20. PubMed ID: 15688088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of Suppressor of Cytokine Signaling 3 (SOCS3) in Altering Activated Microglia Phenotype in APPswe/PS1dE9 Mice.
    Iwahara N; Hisahara S; Kawamata J; Matsumura A; Yokokawa K; Saito T; Fujikura M; Manabe T; Suzuki H; Matsushita T; Suzuki S; Shimohama S
    J Alzheimers Dis; 2017; 55(3):1235-1247. PubMed ID: 27814300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.